業績

{ 332件 }

Fujieda Y, Horita T, Nishimoto N, Tanimura K, Amasaki Y, Kasahara H, Furukawa S, Takeda T, Fukaya S, Matsui K, Tsutsumi A, Furusaki A, Sagawa A, Katayama K, Takeuchi K, Katsuumata K, Kurita T, Shane P, Kato M, Oku K, Yasuda S, Takahata M, Iwasaki N and Atsumi T Efficacy and safety of sodium RISedronate for glucocorticoid-induced OsTeoporosis with rheumaTOid arthritis (RISOTTO study)

: a multicentre, double-blind, randomized, placebo-controlled trial.

Modern Rheumatology (IF 1.78)

  • 2020
  • 膠原病グループ
  • 欧文論文/原著

25回日本血栓止血学会学術奨励賞 久田諒先生

  • 2020
  • 膠原病グループ
  • 受賞

2020年度日本肺高血圧・肺循環学会学会奨励賞臨床研究賞 加藤 将先生

  • 2020
  • 膠原病グループ
  • 受賞

Chiho Oba-Yamamoto, Jun Takeuchi, Akinobu Nakamura, Ryoko Takikawa, Ayano Ozaki, Hiroshi Nomoto, Hiraku Kameda, Kyu Yong Cho, Tatsuya Atsumi, and Hideaki Miyoshi Combination of alcohol and glucose consumption as a risk to induce reactive hypoglycemia J Diabetes Investig, in press

IF: 3.761

  • 2020
  • 糖尿病・内分泌グループ
  • 欧文論文/原著

Kato M*, Hattori T, Shimizu T, Ninagawa K, Izumihara R, Nomoto H, Tanimura K, Atsumi T.

Intrafamilial phenotypic distinction of hypophosphatasia with identical tissue nonspecific alkaline phosphatase gene mutation: A family report Journal of Bone and Mineral Metabolism. in press (*: Correspondence).

IF2.297

  • 2020
  • 膠原病グループ
  • 欧文論文/原著

Nobuya Abe and Yuichiro Fujieda.

Chronic active Epstein-Barr virus infection.

Blood. 2020; in press.

IF 17.543

  • 2020
  • 膠原病グループ
  • 欧文論文/症例報告

Nakazawa D and Ishizu A.

Immunothrombosis in Severe COVID-19.

EBioMedicine. in press

IF 6.490

 

  • 2020
  • 腎臓グループ
  • 欧文論文/総説

OgataY, Fujieda Y, Sugawara M, Sato T, Ohnishi N, Kono M, Kato M, Oku K, Amengual O, Atsumi T Morbidity and mortality in antiphospholipid syndrome based on cluster

analysis: a 10-year longitudinal cohort study Rheumatology

IF:5.245

  • 2020
  • 膠原病グループ
  • 欧文論文/原著

Fujieda Y, Amengual O

New insights into the mechanism and treatment of arterial thrombosis in antiphospholipid syndrome European Journal of Rheumatology

IF:なし

  • 2020
  • 膠原病グループ
  • 欧文論文/総説

Koki Chiba, Hiroshi Nomoto, Akinobu Nakamura, Kyu Yong Cho, Kumiko Yamashita, Yui Shibayama, Aika Miya, Hiraku Kameda, Yoshio Kurihara, Shin Aoki, Tatsuya Atsumi, Hideaki Miyoshi. SGLT2 inhibitors reduce day-to-day glucose variability in patients with type 1 diabetes.

J Diabetes Investig, in press

IF: 3.761

  • 2020
  • 糖尿病・内分泌グループ
  • 欧文論文/原著